Qingdao Vland Biotech INC. (SHA:603739)
China
· Delayed Price · Currency is CNY 15.22
+0.24 (1.60%)
Apr 30, 2026, 9:45 AM CST
SHA:603739 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 3,790 | 3,580 | 3,034 | 3,851 | 3,387 | 4,689 | Upgrade
|
| Market Cap Growth | 7.31% | 18.02% | -21.22% | 13.69% | -27.76% | 34.98% | Upgrade
|
| Enterprise Value | 4,128 | 3,953 | 3,413 | 4,153 | 3,512 | 4,417 | Upgrade
|
| Last Close Price | 14.98 | 14.15 | 11.90 | 15.01 | 13.14 | 18.01 | Upgrade
|
| PE Ratio | 53.50 | 51.29 | 48.44 | 47.72 | 48.50 | 35.37 | Upgrade
|
| Forward PE | - | 45.65 | 30.10 | 29.41 | 29.50 | - | Upgrade
|
| PS Ratio | 2.77 | 2.62 | 2.30 | 3.21 | 2.91 | 4.07 | Upgrade
|
| PB Ratio | 1.98 | 1.87 | 1.62 | 2.11 | 1.95 | 2.78 | Upgrade
|
| P/TBV Ratio | 2.41 | 2.28 | 1.99 | 2.59 | 2.28 | 3.23 | Upgrade
|
| P/FCF Ratio | 111.69 | 105.50 | 33.45 | - | - | - | Upgrade
|
| P/OCF Ratio | 33.26 | 31.42 | 15.53 | 25.07 | 35.54 | 52.38 | Upgrade
|
| EV/Sales Ratio | 3.02 | 2.89 | 2.58 | 3.46 | 3.02 | 3.84 | Upgrade
|
| EV/EBITDA Ratio | 16.47 | 15.77 | 15.18 | 23.48 | 24.16 | 24.35 | Upgrade
|
| EV/EBIT Ratio | 30.79 | 29.49 | 29.83 | 40.27 | 44.08 | 34.05 | Upgrade
|
| EV/FCF Ratio | 121.64 | 116.49 | 37.64 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.36 | 0.36 | 0.34 | 0.40 | 0.30 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 2.71 | 2.71 | 2.83 | 4.09 | 3.60 | 1.30 | Upgrade
|
| Debt / FCF Ratio | 20.00 | 20.00 | 7.01 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.11 | 0.11 | 0.10 | 0.11 | 0.06 | -0.15 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.84 | 0.84 | 0.83 | 1.09 | 0.67 | -1.36 | Upgrade
|
| Net Debt / FCF Ratio | 6.18 | 6.18 | 2.07 | -3.10 | -0.39 | 0.61 | Upgrade
|
| Asset Turnover | 0.45 | 0.45 | 0.44 | 0.43 | 0.49 | 0.63 | Upgrade
|
| Inventory Turnover | 3.63 | 3.63 | 3.69 | 3.42 | 4.01 | 4.40 | Upgrade
|
| Quick Ratio | 0.91 | 0.91 | 0.83 | 0.82 | 1.19 | 2.08 | Upgrade
|
| Current Ratio | 1.17 | 1.17 | 1.04 | 1.03 | 1.50 | 2.61 | Upgrade
|
| Return on Equity (ROE) | 5.16% | 5.16% | 4.99% | 5.78% | 5.00% | 10.72% | Upgrade
|
| Return on Assets (ROA) | 2.78% | 2.78% | 2.38% | 2.30% | 2.08% | 4.42% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.95% | 5.06% | 4.19% | 4.50% | 4.07% | 9.99% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.60% | 6.60% | 5.90% | 5.30% | 4.10% | 7.00% | Upgrade
|
| Earnings Yield | 1.84% | 1.95% | 2.07% | 2.10% | 2.06% | 2.83% | Upgrade
|
| FCF Yield | 0.90% | 0.95% | 2.99% | -1.61% | -7.28% | -8.62% | Upgrade
|
| Dividend Yield | 0.68% | - | 0.84% | 0.67% | 0.76% | 0.89% | Upgrade
|
| Payout Ratio | 61.61% | 61.61% | 88.18% | 49.28% | 75.55% | 28.50% | Upgrade
|
| Buyback Yield / Dilution | 0.49% | 0.49% | 0.66% | 2.50% | -5.36% | -8.14% | Upgrade
|
| Total Shareholder Return | 1.17% | 0.49% | 1.50% | 3.16% | -4.60% | -7.25% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.